NCT02389452 Study of Safety and Efficacy of 6 mL Synvisc-One (Hylan G-F 20) in Indian Patients With Symptomatic Osteoarthritis of Knee(s) After Initial and Repeat Treatment Status COMPLETED Phase PHASE4
NCT02381873 Determinants of Early Functional Outcome After Reconstructive Surgery Status COMPLETED Phase N/A
NCT02370420 Intra-Articular Injections of Platelet-Rich Plasma in Knee Osteoarthritis: Unique Application Versus Triple Application Status COMPLETED Phase PHASE3
NCT02365181 A Trial Between the Intra-articular Local Anesthetic Infiltration With Catheter and Interscalene Block With Catheter in Postoperative Analgesia After Shoulder Prosthesis Status COMPLETED Phase PHASE4
NCT02361359 Preoperative Catastrophizing Predicts Pain Outcome After Shoulder, Knee and Hip Arthroplasty Status COMPLETED Phase N/A
NCT02358447 SPECT-CT for Assessment of Total Knee Arthroplasty in Navigated and Non-navigated Total Knee Arthroplasty Status COMPLETED Phase N/A
NCT02355236 Gastro-protective Effect and Pain Relief Effect of Naxozol Compared to Celecoxib in Patients With Osteoarthritis Status UNKNOWN Phase PHASE4
NCT02352610 A Prospective Randomized Trial Comparing Standard Ligament Reconstruction Tendon Interposition (LRTI) VS Ligament Reconstruction Tendon Interposition (LRTI) With an Interference Screw for Thumb Carpometacarpal Arthritis - Pilot Study Status COMPLETED Phase NA
NCT02350881 Mid-term Outcomes of First MTP Arthroplasty With Primus™ FGT Implant. Status COMPLETED Phase N/A
NCT02350387 Efficacy of Eccentric Resistance Training in Persons With Knee Osteoarthritis Status COMPLETED Phase NA
NCT02343705 Evaluation of the Latella Knee Implant System for Medial Osteoarthritis Pain Reduction (Latella-2 Study) Status TERMINATED Phase NA
NCT02342977 Effects of Lacosamide on Post-operative Opioid Requirements After a Total Hip Arthroplasty: Status WITHDRAWN Phase PHASE2
NCT02341079 Intraoperative Liposomal Bupivacaine Injection in Primary Total Knee Arthroplasty Status WITHDRAWN Phase PHASE2/PHASE3
NCT02336698 Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002 Status COMPLETED Phase PHASE3
NCT02336685 Study of Efficacy, Safety of Fulranumab Adjunctive Use in OA of Hip or Knee, PAI3001 Status COMPLETED Phase PHASE3